The link between oestradiol signalling, GPER and NRF2 has been recognised beyond breast cancer, with the two proteins being interlinked and contributing to attenuated symptoms in atherosclerosis or preventing ferroptotic cell death in lung cancer cell lines (Feng et al., 2021). This evidence concerns the gene NFE2L2 and breast cancer.